Venkateshwaran Krishnaswami and Ruckmani Kandasamy* Pages 2279 - 2282 ( 4 )
The importance of siRNA in nano drug delivery systems to target important pulmonary disorders, such as chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and others, is reviewed in this perspective. The great majority of lung illnesses are caused by protein misfolding. As a result, siRNA-based therapies are increasingly being used to target the gene. Given the difficulties of delivering bare siRNA, siRNA protection may ensure its efficacy in gene therapy. These issues could be solved with a nano-based siRNA delivery systems. In this context, a siRNA-based nanocarrier for major pulmonary disorders has been explored.
siRNA, targeting, pulmonary, nano therapeutics, lung, chronic obstructive pulmonary disease (COPD).